Found 14 matching trials
Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer. PHASE2 The study is being conducted to explore the reasonable dosage and evaluate ...
Show More Location
Harbin Medical University Affiliated Cancer Hospital
Learn More & Join Trial
Phase II, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of HLX43 (an Anti-PD-L1 ADC) in Subjects With Advanced Colorectal Cancer PHASE2 The study is being conducted to to explore the reasonable dosage and evalua...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX43 in Advanced/Metastatic Solid Tumors PHASE1 This study is an open-label first-in-human phase I clinical study to evalua...
Show More Status
Enrolling By Invitation
Location
Stanford University
Learn More & Join Trial
A Phase II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Subjects With Advanced Lung Cancer PHASE2 The study is to explore the the reasonable dosage and to evaluate the effic...
Show More Location
The Second Hospital of Anhui Medical University
Learn More & Join Trial
A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy PHASE2 The study is being conducted to explore the reasonable dosage and evaluate ...
Show More Location
Shandong Cancer Hospital
Learn More & Join Trial
A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC PHASE2 The study is being conducted to to explore the reasonable dosage and evalua...
Show More Location
Shanghai Pulmonary Hospital
Learn More & Join Trial
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC) PHASE2 The study is being conducted to to explore the reasonable dosage and evalua...
Show More Location
MD Anderson Cancer Hospital
Learn More & Join Trial
A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to Standard Therapy PHASE2 The study is being conducted to to explore the reasonable dosage and evalua...
Show More Location
Hunan Cancer Hospital
Learn More & Join Trial
A Phase II Study to Evaluate HLX43 in Subjects With Recurrent/Metastatic Nasopharyngeal Carcinoma Failed or Intolerance to Second-line Therapy PHASE2 The study is to explore the reasonable dosage and to evaluate the efficacy,...
Show More Location
Fujian Cancer Hospital
Learn More & Join Trial
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer PHASE2 The study is being conducted to to explore the reasonable dosage and evalua...
Show More Location
Multiple Locations
Learn More & Join Trial